YZYi Zhu

Yi Zhu

*This is an algorithmically generated author record based on publicly available information.

Yi Zhu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Automated detection of small hepatocellular carcinoma in cirrhotic livers: applying deep learning to Gd-EOB-DTPA-enhanced MRI

    by JunQiang Lei, YongSheng Xu, YuanHui Zhu, ShanShan Jiang, Song Tian, Yi Zhu

    Objectives To develop an automated deep learning (DL) methodology for detecting small hepatocellular carcinoma (sHCC) in cirrhotic livers, leveraging Gd-EOB-DTPA-enhanced MRI. Methods The present retrospective study included a total of 120 patients with cirrhosis, comprising 78 patients with sHCC and 42 patients with non-HCC cirrhosis, who were selected through stratified sampling. The dataset was divided into training and testing sets (8:2 ratio). The nnU-Net exhibits enhanced capabilities in segmenting small objects. The segmentation performance was assessed using the Dice coefficient. The ability to distinguish between sHCC and non-HCC lesions was evaluated through ROC curves, AUC scores and P values. The case-level detection performance for sHCC was evaluated through several metrics: accuracy, sensitivity, and specificity. Results The AUCs for distinguishing sHCC patients from non-HCC patients at the lesion level were 0.967 and 0.864 for the training and test cohorts, respectively, both of which were statistically significant at P < 0.001. At the case level, distinguishing between patients with sHCC and patients with cirrhosis resulted in accuracies of 92.5% (95% CI, 85.1–96.9%) and 81.5% (95% CI, 61.9–93.7%), sensitivities of 95.1% (95% CI, 86.3–99.0%) and 88.2% (95% CI, 63.6–98.5%), and specificities of 87.5% (95% CI, 71.0–96.5%) and 70% (95% CI, 34.8–93.3%) for the training and test sets, respectively. Conclusion The DL methodology demonstrated its efficacy in detecting sHCC within a cohort of patients with cirrhosis. Graphical Abstract